These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3079800)

  • 1. Organ-associated macrophage precursor activity: isolation of candidacidal and tumoricidal effectors from the spleens of cyclophosphamide-treated mice.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1986 Feb; 136(3):837-43. PubMed ID: 3079800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-associated macrophage precursors as natural cytotoxic effectors against Candida albicans and Yac-1 cells.
    Decker T; Baccarini M; Lohmann-Matthes ML
    Eur J Immunol; 1986 Jun; 16(6):693-9. PubMed ID: 3522245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1985 Apr; 134(4):2658-65. PubMed ID: 3882833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage precursors as natural killer cells against tumor cells and microorganisms.
    Baccarini M; Hao L; Decker T; Lohmann-Matthes ML
    Nat Immun Cell Growth Regul; 1988; 7(5-6):316-27. PubMed ID: 2906114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of cyclophosphamide and thymostimulin treatment on the in vitro natural killer and candidacidal activity of murine spleen cells.
    Baccarini M; Scaringi L; Puccetti P; Falchetti R; D'Errico P; Bistoni F
    Int J Tissue React; 1984; 6(6):485-92. PubMed ID: 6530352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional heterogeneity of macrophage precursor cells from spleen of Leishmania donovani-infected and untreated mice.
    Hockertz S; Baccarini M; Lohmann-Matthes ML
    J Immunol; 1989 Apr; 142(7):2489-94. PubMed ID: 2926141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of non-specific cytotoxic cells in Listeria-susceptible and -resistant mouse strains.
    Wood P; Cheers C
    Immunology; 1985 Jan; 54(1):113-9. PubMed ID: 3918933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.
    Hackett J; Tutt M; Lipscomb M; Bennett M; Koo G; Kumar V
    J Immunol; 1986 Apr; 136(8):3124-31. PubMed ID: 3958492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adriamycin on the activity of mouse natural killer cells.
    Santoni A; Riccardi C; Sorci V; Herberman RB
    J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the activity of mouse natural killer cells by urethan.
    Gorelik E; Herberman RB
    J Natl Cancer Inst; 1981 Mar; 66(3):543-8. PubMed ID: 6937709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
    Hackett J; Bennett M; Kumar V
    J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in tumor-associated NK 1.1+ large granular lymphocyte precursors after cyclophosphamide injection: in vitro characterization and potential therapeutic application.
    Krupke DM; Fuller J; Aslakson C; Evans R
    Nat Immun; 1994; 13(5):246-57. PubMed ID: 7833624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional heterogeneity of murine macrophage precursor cells from spleen and bone marrow.
    Baccarini M; Kiderlen AF; Decker T; Lohmann-Matthes ML
    Cell Immunol; 1986 Sep; 101(2):339-50. PubMed ID: 3489536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    Suzuki R; Handa K; Itoh K; Kumagai K
    J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
    Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
    J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
    Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
    Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.